The prospective Fracture Intervention Trial Long-term Extension ( FLEX ) study randomized postmenopausal women aged 61 to 86 years previously treated with 4 to 5 years of alendronate therapy to 5 more years of alendronate or placebo from 1998 through 2003 ; the present analysis includes only the placebo group .